Reggiani, Francesca http://orcid.org/0000-0002-4090-8908
Talarico, Giovanna
Gobbi, Giulia
Sauta, Elisabetta
Torricelli, Federica
Manicardi, Veronica
Zanetti, Eleonora
Orecchioni, Stefania
Falvo, Paolo http://orcid.org/0000-0001-5743-5046
Piana, Simonetta
Lococo, Filippo
Paci, Massimiliano
Bertolini, Francesco http://orcid.org/0000-0001-5660-3255
Ciarrocchi, Alessia http://orcid.org/0000-0002-5541-2075
Sancisi, Valentina http://orcid.org/0000-0003-4357-1228
Funding for this research was provided by:
Ministero della Salute (Bando per la Valorizzazione della Ricerca Istituzionale 2021 – Fondi 5 per Mille 2016)
Associazione Italiana per la Ricerca sul Cancro (IG26377, IG20109, IG21772)
Fondazione Umberto Veronesi (Fellowship)
Article History
Received: 31 March 2023
Accepted: 11 March 2024
First Online: 22 March 2024
Competing interests
: The authors declare no competing interests.
: The research workflow was discussed amongst all collaborators and experimental work was executed accordingly. Researchers were involved at all locations in Italy where the research work was conducted. The experiments on humans and on mice were conducted according to Italian laws and institutional guidelines and approved by the competent Committees: animal experiments were approved by institutional and national committees (Authorization 780/2020-PR released by the Italian Ministry of Health). The study on humans was approved by the local ethical committee (Comitato Etico dell’Area Vasta Emilia Nord (AVEN)—Reggio Emilia district, Italy, authorization code 196/2017). All patients were informed and signed a written consensus. Patients had the right to withdraw their consensus at any time. Biological and chemical risk for researchers was managed according to Institutional guidelines.